Here’s to the Next 25

Feinstein Kean Healthcare has spent the past 25 years laboring productively in the vineyards of disruptive innovation. The firm was born in the cradle of biotech and worked with many of the industry’s pioneers. We were there in the early days of stem cell research, oncogenes and immunotherapies, nanotech, many of the “omics” and, more recently, big data, cognitive gaming and the digitization of medicine. We’ve helped to open up entirely new categories of treatment in many disease areas, and changed the mindset in others. We were the first in the communications industry to anticipate the impact of personalized medicine—and (thanks...